(Albany, US) DelveInsight launched a new report on ‘Peanut Allergy – Epidemiology Forecast to 2030‘.
DelveInsight’s ‘Peanut Allergy – Epidemiology Forecast to 2030‘ report delivers an in-depth understanding of the disease, historical and forecasted Peanut Allergy epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Some of the facts of the report
1. As per DelveInsight estimates, total prevalent population of Peanut Allergy in the 7MM was found to be 8,640,527 in 2017.
2. As per DelveInsight analysis, it is observed that, Japan has the least number of prevalent cases (1,548,318 for 2017) of Peanut Allergy, among the 7MM.
3. The total cases of mild and moderate to severe Peanut Allergy in the US varied as 2,341,384 and 1,153,219 respectively.
“According to DelveInsight, most of the patients diagnosed with Peanut Allergy were male.”
Food allergy is an abnormal response to a food triggered by the body’s immune system. There are several types of immune response to food. A peanut allergy is an allergic reaction to peanuts which occurs when the human body mistakenly identifies peanuts as harmful substances. Peanut allergy is recognized as one of the most severe food allergies due to its prevalence, persistency, and the potential severity of the allergic reaction. Although other food allergies occurring in childhood usually resolve spontaneously with age, peanut sensitivity appears early in life and often persists indefinitely.
Frequently, large quantities of peanut allergens are not needed to elicit an allergic reaction- even trace levels of peanut are capable of causing a hypersensitive reaction.
The symptoms of peanut allergy vary from mild to severe, from swollen lips, shortness of breath to ananaphylactic shock, which is potentially fatal.
– Mild to moderate symptoms are: Itchy skin or hives, which can appear as small spots or largewelts, an itching or tingling sensation in or around the mouth or throat, nausea, a runny or congested nose.
– The most severe allergic reaction to peanuts is anaphylaxis, a life-threatening whole-body response to an allergen. Symptoms include impaired breathing, swelling in the throat, a sudden drop in blood pressure, pale skin or blue lips, fainting and dizziness.
“According to DelveInsight, Among the EU5 countries, France had the highest prevalent population of Peanut Allergy with 614,959 cases, followed by Germany and the United Kingdom. “
Request for sample pages : https://www.delveinsight.com/sample-request/peanut-allergy-epidemiology-forecast
Scope of the Report
- The Peanut Allergy report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
- The Peanut Allergy Epidemiology Report and Model provide an overview of the risk factors and global trends of Peanut Allergy in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
- The report provides insight about the historical and forecasted patient pool of Peanut Allergy in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
- The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
- The report assesses the disease risk and burden and highlights the unmet needs of Peanut Allergy
- The report provides the segmentation of the Peanut Allergy epidemiology
KOL- Views
We interview, KOLs and SME’s opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.
Request for sample pages : https://www.delveinsight.com/sample-request/peanut-allergy-epidemiology-forecast
Key Questions Answered
- What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Peanut Allergy?
- What are the key findings pertaining to the Peanut Allergy epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?
- What would be the total number of patients of Peanut Allergy across the 7MM during the forecast period (2017-2030)?
- Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?
- At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?
- What is the disease risk, burden and unmet needs of the Peanut Allergy?
- What are the currently available treatments of Peanut Allergy?
Reasons to buy
- The Peanut Allergy Epidemiology report will allow the user to –
- Develop business strategies by understanding the trends shaping and driving the global Peanut Allergy market
- Quantify patient populations in the global Peanut Allergy market to improve product design, pricing, and launch plans
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Peanut Allergy therapeutics in each of the markets covered
- Understand the magnitude of Peanut Allergy population by its epidemiology
- The Peanut Allergy Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources
Key Assessments
- Patient Segmentation
- Disease Risk and Burden
- Risk of disease by the segmentation
- Factors driving growth in a specific patient population
Related Reports:
Peanut Allergy Market Insight, Epidemiology and Market Forecast -2030
The Peanut Allergy market report provides current treatment practices, emerging drugs, Peanut Allergy market share of the individual therapies, current and forecasted Peanut Allergy market Size from 2017 to 2030 segmented by seven major markets.
Peanut Allergy – Pipeline Insights, 2020
The Peanut Allergy report provides an overview of therapeutic pipeline activity and therapeutic assessment of the products by development stage, product type, route of administration, molecule type, and MOA type for Peanut Allergy across the complete product development cycle, including all clinical and nonclinical stages.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/